APA (7th ed.) Citation

Golocorbin-Kon, S., Calasan, J., Milijasevic, B., Vukmirovic, S., Lalic-Popovic, M., Mikov, M., & Al-Salami, H. (2017). High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect. Springer France.

Chicago Style (17th ed.) Citation

Golocorbin-Kon, S., J. Calasan, B. Milijasevic, S. Vukmirovic, M. Lalic-Popovic, M. Mikov, and Hani Al-Salami. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect. Springer France, 2017.

MLA (9th ed.) Citation

Golocorbin-Kon, S., et al. High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect. Springer France, 2017.